Next PMDA Consultation after Review of CardiAMP HF Trial Data. SUNNYVALE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and ...

Konica Minolta Healthcare Americas, Inc., a leading provider of medical diagnostic imaging and imaging information technology, and Gleamer, a leading European developer of artificial intelligence (AI) ...

SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Adaptive Research and Western Radiation Oncology (WRO) have announced that WRO has joined Adaptive Research’s growing network of community physician ...

Redefining Advocacy for the Injured and The Unsettling Truth About Settling ...

CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- B&D Nutritional Ingredients, Inc., a raw material distributor in the dietary supplement industry and exclusive U.S. distribution partner to CarnoSyn ...

For years, Oxford Treatment Center has been dedicated to helping individuals find recovery from substance use and co-occurring disorders. With treatment services ranging from medical detox and ...

Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

OmniScience is a trusted partner to leading life science organizations, advancing clinical R&D missions through unparalleled expertise in clinical data science. We believe in a future where all ...

“We are pleased to have Jeannine join us to manage our financial affairs. Our businesses will greatly benefit from her extensive skills and knowledge,” stated Promex and QP Technologies CEO Richard ...

We are incredibly honored to be recognized alongside the leading, global healthcare companies,” said Gregory T. Lucier, ...

LAS VEGAS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) Board of Directors has approved a dividend to all common stockholders. They will receive matching shares for all of ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...